Table: begin end state 1 5 non-cytoplasmic 6 25 transmembrane 26 55 cytoplasmic 56 81 transmembrane 82 86 non-cytoplasmic 87 108 transmembrane 109 127 cytoplasmic 128 155 transmembrane 156 160 non-cytoplasmic 161 179 transmembrane 180 190 cytoplasmic 191 208 transmembrane 209 221 non-cytoplasmic 222 243 transmembrane 244 254 cytoplasmic 255 272 transmembrane 273 291 non-cytoplasmic 292 313 transmembrane 314 326 cytoplasmic 327 351 transmembrane 352 357 non-cytoplasmic 358 376 transmembrane 377 387 cytoplasmic 388 406 transmembrane 407 415 non-cytoplasmic 416 435 transmembrane 436 461 cytoplasmic 462 481 transmembrane 482 488 non-cytoplasmic 489 513 transmembrane 514 520 cytoplasmic 521 543 transmembrane 544 556 non-cytoplasmic 557 579 transmembrane 580 602 cytoplasmic
Input: >WP_046157472.1 NCBI__GCF_000971335.1:WP_046157472.1 MDHALSFVIGTLCILAICYRLYGVFFTRKVLGVDDSAVTPSHELKDGKDYVPTSKWVAFG GHFAAIAAAGPLVGPVLAAQYGYLPSMIWLLIGCVIGGAVHDTVVLFASMKHHGKSLSEV AKAELGPVAGWCTGLAMLFIITITMAGLSMVVVHALERNPWGAFAVFMTIPIAIGVGLWE RMTGSMKNASYVGIAAIMACVFAGPYIQHTALGEWLSLKASTVSLLLPIYAFFATALPVW MLLTPRACLSSFMKIGVFGLLVVGVVFINPQIQFPAVTQFIHGGGPVLSGPVWPFISITI ACGAISGFHAFIGSGTTPKQIDKWSDILPVGFGAMLAECVVGVMALIAATALHPADYFAI NSAPAVFQTLGMDVVNLPKLSQEIGLDLYGRTGGAVTLAVGMADIFTRIPWFSHLASYFF QFMVMFEAVFILTAIDSGTRVARYLIQDFVGDLWAPLKRTDWMPGAIGASVVACAMWGYL LNSGDINSVWALFGVSNQLMASIGLIIGATIILRLSHKRSYMLTCLVPLAYLYVTVNYAG YWMVKNVYLNPAAKGYNVFNAGISIVMLALGLVILISAVRRWKALLGRPAPQAGLKPAAA EA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server